Logo

Suggestions

  • Cancer Disparities
  • Opinion
  • Conferences
  • News
  • Patient Corner
  • About
    • Contact
    • Article Submission
  • Top Headlines
    • Cancer Types
      • Breast Cancer
      • Cervical Cancer
      • GI Malignancies
      • Melanoma & Skin Cancer
      • GU Malignancies
      • Gynecologic Oncology
      • Hematologic Malignancies
      • Lung Cancer
  • Expert Opinion
  • Video News
  • New Approvals
  • Cancer Disparities
  • Patient Corner
  • Subscribe

Logo

hematologic malignancies

Dr_Luke_Fletcher
June 7, 2023
Hematologic Malignancies/Opinion

Highlights of ASCO: MDS COMMANDS Study

By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center   Low-risk MDS had many exciting updates, starting with the COMMANDS trial. This study is an open-label randomized phase 3 trial

Dr_Luke_Fletcher
Hematologic Malignancies/News

Updates at ASCO: The Phase 3 IMerge Study

Imetelstat in low-risk MDS for transfusion independence   By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center   ASCO presented an anticipated update to imetelstat in MDS. In the phase 3 IMerge study (ClinicalTrials.gov identifier NCT02598661), imetelstat improved

June 7, 2023

Highlights of ASCO: Hodgkin’s Lymphoma S1826 Study

Hematologic Malignancies/News

By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center   Hodgkin’s lymphoma (HL) has had an exciting and interesting recent history with

Four Oncology Conferences Held in October 2021

Conferences/Events/Hematologic Malignancies

The Binaytara Foundation organized three in-person oncology conferences in October 2021. The 2021 Updates in Hematologic Malignancies and the 2021 Precision Oncology Summit were

FDA_Approved
New Approvals/News

FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes

On August 28, 2023, the U.S. Food and Drug Administration approved luspatercept-aamt (Reblozyl) for the treatment of anemia in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) without prior erythropoiesis-stimulating agent (ESA) use,

More
by Tara Shah
September 20, 2023
Dr_Luke_Fletcher
Hematologic Malignancies/News

Highlights of ASCO: Hodgkin’s Lymphoma S1826 Study

By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center   Hodgkin’s lymphoma (HL) has had an exciting and interesting recent history with the introduction of brentuximab (BV) +AVD (Adriamycin, vinblastine,

More
by Staff Writer - The Cancer News
June 7, 2023
Dr_Luke_Fletcher
Hematologic Malignancies/News

Updates at ASCO: The Phase 3 IMerge Study

Imetelstat in low-risk MDS for transfusion independence   By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center   ASCO presented an anticipated update to imetelstat in MDS. In the phase

More
by Staff Writer - The Cancer News
June 7, 2023
Dr_Luke_Fletcher
Hematologic Malignancies/Opinion

Highlights of ASCO: MDS COMMANDS Study

By Dr. Luke Fletcher Willamette Valley Cancer Institute & Research Center   Low-risk MDS had many exciting updates, starting with the COMMANDS trial. This study is an open-label randomized phase 3 trial

More
by Staff Writer - The Cancer News
June 7, 2023
Hematologic Malignancies/Opinion

A Summary of the DACOTA Trial

By Dr. Chepsy Philip Believer’s Church Medical College Hospital   Myeloproliferative – Chronic Myelomonocytic Leukemia (MP-CMML), a subset in the rare patient population of CMML, is associated with poor prognosis. Hydroxyurea (HY)

More
by Staff Writer - The Cancer News
May 3, 2023
Hematologic Malignancies/Opinion

Updated Results from the ASCEMBL Trial

By Dr. Aditi Sharma of Barbara Ann Karmanos Cancer Institute & Dr. Abhishek Mangaonkar of Mayo Clinic   In the longer-term follow-up of the phase III ASCEMBL trial published in Leukemia, Andreas

More
by Staff Writer - The Cancer News
May 2, 2023
Placeholder Photo
Conferences/Events/Hematologic Malignancies

Four Oncology Conferences Held in October 2021

The Binaytara Foundation organized three in-person oncology conferences in October 2021. The 2021 Updates in Hematologic Malignancies and the 2021 Precision Oncology Summit were held in Salt Lake City, Utah on October

More
by Staff Writer - The Cancer News
November 3, 2021

your advertisement here

you may also like...

  • targeted-therapy
    Antibody Drug Conjugates
  • FDA_Approved
    FDA Approves Luspatercept-aamt for Anemia in Patients with Myelodysplastic Syndromes
  • hodgkin-lymphoma
    KEYNOTE-087: Pembrolizumab Monotherapy for Relapsed/Refractory Classical Hodgkin lymphoma
  • Overview of KEYNOTE-671 & NADIM II
  • Expert Opinion: Children’s Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse

All Categories

  • Awareness
  • Breast Cancer
  • Cancer Disparities
  • Cancer Research
  • Conference 2023
  • Conference Coverage
  • Conferences
  • Events
  • GI Malignancies
  • GU Malignancies
  • Hematologic Malignancies
  • Journal
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Nepal Cancer Center
  • New Approvals
  • New Drug Applications
  • News
  • Opinion
  • Patient Corner
  • Spotlights
  • Uncategorized
  • Updates
  • Video News
  • Volunteer Spotlight

Search By Keyword

ASCO ASCO23 award Binaytara foundation breast cancer BTF cancer cancer care cancer disparities cancer research cancer survival cancer treatment Cellular therapy CME conference Conferences continuing education Dr. Binay Shah Dr Anish Shah Dr Shipra Gandhi Expert Opinion faculty highlight FDA FDA Approval FDA approved head & neck cancer surgery in Nepal healthcare equity hematological malignancies hematologic malignancies leukemia Lung cancer lymphoma multiple myeloma Nepal cancer care oncology CME SCHD video news Volunteer

We Transform Cancer Care

Dissect complex information on cancer and disseminate knowledge to healthcare professionals, patients, and caregivers. We want to improve patient outcomes.
Cover the latest research to promote precision oncology and patient-centered care.
Questions? Contact us -
[email protected]

Social Media

Advertisement


Footer Logo
  • Facebook
  • Twitter
  • LinkedIn

© 2023 - All Rights Reserved. Binaytara Foundation

  • About
  • Submit an Article
  • Subscribe for updates
  • Editorial Board
  • Privacy Policy
  • Contact
  • Home
  • Top Headlines
    • Awareness
    • Video News
    • Cancer Types
      • Breast Cancer
      • Cervical Cancer
      • Melanoma & Skin Cancer
      • GI Malignancies
      • Lung Cancer
      • Hematologic Malignancies
      • Gynecologic Oncology
      • GU Malignancies
  • New in Cancer Care
  • Conferences
    • Hemotology & Oncology Conference Calendar
    • Conference Calendar
    • Conference Coverage
  • New Approvals
  • Contact us
  • Submit an article